Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human-derived recombinant FSH for controlled ovarian

Human-derived recombinant FSH for controlled ovarian

US Patent 12478660 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxytocin receptor antagonist therapy in the luteal phase for implantation and pr2023
Methods of treating infertility2023
Methods of treating infertility2022
Human-derived recombinant FSH for controlled ovarian stimulation2022
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pr2020
Human-derived recombinant FSH for controlled ovarian stimulation2020
Methods of treating infertility2019
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pr2019
FSH composition and methods for controlled ovarian stimulation2017
Oxytocin receptor antagonist therapy in the luteal phase for implantation and pr2017
Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopa2012